Harvard Bioscience Inc (HBIO)
2.255
-0.04
(-1.53%)
USD |
NASDAQ |
Nov 15, 10:49
Harvard Bioscience Cash and Short Term Investments (Quarterly): 4.569M for Sept. 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 4.569M |
| June 30, 2024 | 4.048M |
| March 31, 2024 | 4.255M |
| December 31, 2023 | 4.283M |
| September 30, 2023 | 5.34M |
| June 30, 2023 | 4.324M |
| March 31, 2023 | 3.789M |
| December 31, 2022 | 4.508M |
| September 30, 2022 | 5.144M |
| June 30, 2022 | 4.259M |
| March 31, 2022 | 5.433M |
| December 31, 2021 | 7.821M |
| September 30, 2021 | 5.548M |
| June 30, 2021 | 6.237M |
| March 31, 2021 | 5.815M |
| December 31, 2020 | 8.317M |
| September 30, 2020 | 2.806M |
| June 30, 2020 | 2.629M |
| March 31, 2020 | 5.882M |
| December 31, 2019 | 8.335M |
| September 30, 2019 | 6.845M |
| June 30, 2019 | 4.934M |
| March 31, 2019 | 5.03M |
| December 31, 2018 | 8.173M |
| September 30, 2018 | 6.661M |
| Date | Value |
|---|---|
| June 30, 2018 | 5.624M |
| March 31, 2018 | 5.991M |
| December 31, 2017 | 5.192M |
| September 30, 2017 | 5.836M |
| June 30, 2017 | 4.724M |
| March 31, 2017 | 4.599M |
| December 31, 2016 | 5.596M |
| September 30, 2016 | 5.345M |
| June 30, 2016 | 3.631M |
| March 31, 2016 | 4.175M |
| December 31, 2015 | 6.744M |
| September 30, 2015 | 6.09M |
| June 30, 2015 | 7.402M |
| March 31, 2015 | 8.031M |
| December 31, 2014 | 14.13M |
| September 30, 2014 | 26.73M |
| June 30, 2014 | 26.43M |
| March 31, 2014 | 25.84M |
| December 31, 2013 | 25.77M |
| September 30, 2013 | 36.93M |
| June 30, 2013 | 34.10M |
| March 31, 2013 | 23.75M |
| December 31, 2012 | 20.68M |
| September 30, 2012 | 20.28M |
| June 30, 2012 | 18.66M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
2.629M
Minimum
Jun 2020
8.335M
Maximum
Dec 2019
5.167M
Average
4.856M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Bruker Corp | 148.10M |
| Azenta Inc | 595.84M |
| Bionano Genomics Inc | 18.94M |
| Akoya Biosciences Inc | 45.22M |
| Singular Genomics Systems Inc | 133.20M |